TD Asset Management Inc Increases Stock Position in Chemed Co. (NYSE:CHE)

TD Asset Management Inc lifted its stake in Chemed Co. (NYSE:CHEFree Report) by 164.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 205,777 shares of the company’s stock after purchasing an additional 127,934 shares during the quarter. TD Asset Management Inc owned 1.37% of Chemed worth $120,328,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently modified their holdings of CHE. GAMMA Investing LLC purchased a new position in shares of Chemed in the 4th quarter worth about $37,000. Principal Securities Inc. purchased a new position in Chemed in the 4th quarter worth about $51,000. SRS Capital Advisors Inc. raised its position in Chemed by 110.6% in the 4th quarter. SRS Capital Advisors Inc. now owns 99 shares of the company’s stock worth $58,000 after buying an additional 52 shares during the last quarter. Covestor Ltd raised its position in Chemed by 27.4% in the 3rd quarter. Covestor Ltd now owns 144 shares of the company’s stock worth $75,000 after buying an additional 31 shares during the last quarter. Finally, Larson Financial Group LLC grew its stake in shares of Chemed by 86.9% during the 4th quarter. Larson Financial Group LLC now owns 157 shares of the company’s stock valued at $92,000 after purchasing an additional 73 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the company. Oppenheimer boosted their price target on Chemed from $625.00 to $650.00 and gave the company an “outperform” rating in a research note on Thursday, February 29th. Royal Bank of Canada cut their price target on Chemed from $712.00 to $697.00 and set an “outperform” rating for the company in a research note on Tuesday, May 21st. Finally, StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, May 4th.

Get Our Latest Stock Analysis on CHE

Insider Activity at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 4,000 shares of the company’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $567.54, for a total value of $2,270,160.00. Following the completion of the transaction, the chief executive officer now directly owns 108,549 shares in the company, valued at approximately $61,605,899.46. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Chemed news, CEO Kevin J. Mcnamara sold 4,000 shares of the company’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $567.54, for a total value of $2,270,160.00. Following the completion of the transaction, the chief executive officer now directly owns 108,549 shares in the company, valued at approximately $61,605,899.46. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Spencer S. Lee sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total value of $1,283,300.00. Following the completion of the transaction, the executive vice president now owns 20,760 shares of the company’s stock, valued at $13,320,654. The disclosure for this sale can be found here. In the last ninety days, insiders sold 19,808 shares of company stock worth $12,454,691. 3.32% of the stock is owned by company insiders.

Chemed Price Performance

Shares of NYSE:CHE traded down $3.20 during mid-day trading on Wednesday, reaching $540.14. 21,881 shares of the company traded hands, compared to its average volume of 79,394. The company’s 50 day moving average price is $596.87 and its 200-day moving average price is $594.77. The firm has a market cap of $8.18 billion, a PE ratio of 29.26, a PEG ratio of 2.27 and a beta of 0.46. Chemed Co. has a 52 week low of $492.84 and a 52 week high of $654.62.

Chemed (NYSE:CHEGet Free Report) last announced its quarterly earnings data on Wednesday, April 24th. The company reported $4.68 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.09 by ($0.41). The company had revenue of $589.23 million for the quarter, compared to the consensus estimate of $587.18 million. Chemed had a net margin of 12.36% and a return on equity of 30.52%. On average, research analysts predict that Chemed Co. will post 21.72 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 18th. Investors of record on Thursday, May 30th will be paid a dividend of $0.40 per share. The ex-dividend date is Thursday, May 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.30%. Chemed’s dividend payout ratio (DPR) is presently 8.61%.

About Chemed

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Stories

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.